Cancer anal. Tratamiento con radioterapia y quimioterapia exclusiva.

Translated title of the contribution: Anal neoplasms. Treatment with radiotherapy and exclusive chemotherapy
  • S. San Martín*
  • , S. Armando
  • , J. Arraztoa
  • , Y. Morales
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

We report preliminary results on treatment of anal carcinoma by radiotherapy and chemotherapy. Nine patients (mean age 64, 6 females) were treated with 5-fluorouracil and mitomycin C intravenously, associated to radiotherapy (3000 rads in 10 days). The lesion was located in the anal canal in 4 patients and at the anal margin in 5. Good response was observed in every patient with no evidence of recurrence during a 2 to 30 month follow up period (median 16). A greater number of patients and a longer follow up period is required to establish this as a valid alternative to abdomino-perineal surgery for the treatment of anal carcinoma.

Translated title of the contributionAnal neoplasms. Treatment with radiotherapy and exclusive chemotherapy
Original languageSpanish
Pages (from-to)1137-1140
Number of pages4
JournalRevista Medica de Chile
Volume117
Issue number10
StatePublished - Oct 1989
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Anal neoplasms. Treatment with radiotherapy and exclusive chemotherapy'. Together they form a unique fingerprint.

Cite this